Rio de Janeiro: Brazil’s health regulator Anvisa has said that Covaxin did not meet its manufacturing standards.
The Brazilian government had signed a contract in February to buy 20 million doses of the COVID-19 vaccine, which has been developed by Indian company Bharat Biotech.
The Brazilian government signed a contract last month to buy 20 million doses of Covaxin, Reuters reported. Bharat Biotech applied for emergency use of the vaccine in Brazil on March 8.
Following the Brazilian regulator’s announcement, Bharat Biotech and its Brazilian partner Precisa Medicamentos stated that they will appeal the decision and present evidence that the vaccine complies with all requirements.
The statement further mentioned that Covaxin has been approved for use in five countries.
Brazil, which reported a record 3,780 coronavirus deaths on Monday, currently accounts for about a quarter of COVID-19 daily deaths worldwide.
New Delhi/Bhubaneswar: While the 43rd India International Trade Fair (IIYF) enters its fifth day in…
Bhubaneswar: A team of AIIMS in Bhubaneswar saved the life of a young man, whose…
Mumbai: It's known to all that all is not well in Abhishek Bachchan and Aishwarya…
Cuttack: All cultural programmes at Cuttack Bali Jatra scheduled for Monday have been cancelled in…
New Delhi: India has got its 56th Tiger Reserve. Located in Chhattisgarh’s Ramkola, the Guru Ghasidas-Tamor…
Bhubaneswar: The Odisha government will start the procurement of kharif paddy at a mandi in…
Bhubaneswar: A 200 years old Banyan tree outside Lingaraj Road railway station in Odisha capital…
New Delhi: Whenever Prime Minister Narendra Modi embarks on overseas visits, the Indian community never fails…